149th Meeting of the National Advisory Council on Drug Abuse | National Institute on Drug Abuse (NIDA)

Virtual Meeting – May 13, 2025

Closed Session

This meeting is closed to the public in accordance with the provisions set forth in section 552b{c}(4) and 552b{c}(6), Title 5, U.S. Code and section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.
C.Appendix 2).

Time	Presentation
9:00 a.m.	Call to Order Nora Volkow, M.D. Director, NIDA Review of Policy and Procedures Susan Weiss, Ph.D. Executive Secretary National Advisory Council on Drug Abuse Director, Division of Extramural Research, NIDA
9:15 a.m.	Council Review of Grant Applications Nora Volkow, M.D., Director, NIDA Division of Neuroscience and Behavior (DNB) Tristan McClure-Begley, Ph.D., Acting Director Division of Epidemiology, Services, and Prevention Research (DESPR) Carlos Blanco, M.D., Ph.D., Director Office of Translational Initiatives and Program Innovationa (OTIPI) Elena Koustova, Ph.D., M.B.A., Director Division of Therapeutics and Medical Consequences (DTMC) Iván Montoya, M.D., M.P.H., Director
	Brief Break
10:15 a.m.	Report to Council from the Board of Scientific Counselors (BSC) Amy Newman, Ph.D., Director, NIDA IRP John Mantsch, Ph.D., BSC Chair
10:45 a.m.	Break

May 7, 2025